Executive Summary
Across 78 SEC filings on February 4, 2026, for the USA Dow Jones 30 intelligence stream, a dominant theme is an unprecedented cluster of ~42 earnings-related disclosures (Item 2.02), all with neutral sentiment and no disclosed quantitative metrics such as YoY/QoQ revenue growth, margins, or guidance changes, limiting period-over-period trend synthesis but signaling the kickoff of Q4 2025 earnings season with high materiality (avg 7/10). A secondary pattern emerges in 12 M&A/transaction filings (Items 1.01/2.01), suggesting active dealmaking for growth amid neutral market conviction. Leadership churn affects 12 companies via Item 5.02 officer/director changes, raising subtle governance risks without specific details on departures vs appointments. Two mixed sentiment cases (Orion Group Holdings, PAVmed Inc.) highlight acquisition opportunities offset by debt creation (Item 2.03) and equity dilution (Item 3.02), while no insider trading, capital allocation details (dividends/buybacks), financial ratios, or scheduled events are disclosed across filings. Portfolio-level implications point to neutral near-term momentum for DJ30 constituents (inferred via stream focus), with alpha potential in M&A outliers but broad volatility from earnings blackouts. No overarching period trends identifiable (e.g., no aggregate margin compression or revenue acceleration), emphasizing need to drill into exhibits for enriched operational metrics.
Tracking the trend? Catch up on the prior Dow Jones 30 Stocks SEC Filings digest from February 02, 2026.
Investment Signals(12)
- MicroVision, Inc.β(BULLISH)β²
Completed acquisition/disposition of assets (Item 2.01), high materiality 8/10 with potential strategic benefits, no negative metrics disclosed
- Orion Group Holdings Inc.β(BULLISH)β²
Acquisition completion (Item 2.01) with pro forma financials in exhibits, outweighing debt/equity risks per mixed sentiment analysis
- Medalist Diversified REIT, Inc.β(BULLISH)β²
Entry into material definitive agreement (Item 1.01), materiality 8/10 signaling expansion potential
- CECO Environmental Corpβ(BULLISH)β²
Material definitive agreement (Item 1.01) plus financial obligation (Item 2.03), large 2MB filing suggests detailed terms
- VSE Corpβ(BULLISH)β²
Material definitive agreement (Item 1.01), materiality 7/10 with exhibits for valuation insights
- PAVmed Inc.β(BULLISH)β²
New material agreement (Item 1.01) terminating prior one (Item 1.02), potential improved financing despite dilution
- Revolve Group, Inc.β(BULLISH)β²
Material definitive agreement (Item 1.01), high materiality 8/10 amid off-balance sheet obligations
- GenFlat Holdings, Inc.β(BULLISH)β²
Material definitive agreement (Item 1.01) with Reg FD disclosure, strategic partnership opportunity
- CION Investment Corpβ(BULLISH)β²
Material definitive agreement (Item 1.01), materiality 8/10 for potential portfolio expansion
- Vivakor, Inc.β(BULLISH)β²
Material definitive agreement (Item 1.01), materiality 8/10 despite equity sales
- Kingstone Companies, Inc.β(BULLISH)β²
Earnings results (Item 2.02), high materiality 8/10 with multi-item filing
- AbbVie Inc.β(BULLISH)β²
Earnings disclosure (Item 2.02), materiality 7/10 as potential DJ30 proxy leader
Risk Flags(10)
- Orion Group Holdings/Dilution & Debtβ[HIGH RISK]βΌ
Unregistered equity sales (Item 3.02) + financial obligations (Item 2.03), medium risk with integration concerns
- PAVmed Inc./Restructuring Risksβ[HIGH RISK]βΌ
Terminated agreement (Item 1.02), equity sales (Item 3.02), bylaws amendments (Item 5.03), mixed sentiment medium risk
- Midland States Bancorp/Officer Changeβ[MEDIUM RISK]βΌ
Undisclosed officer departure/appointment (Item 5.02), potential governance issues
- Lamb Weston Holdings/Leadershipβ[MEDIUM RISK]βΌ
Officer/director change (Item 5.02), undisclosed reasons/timing
- CHOICEONE FINANCIAL SERVICES/Officer Changeβ[MEDIUM RISK]βΌ
Officer change + Reg FD (Item 7.01), critical details NOT_DISCLOSED, medium risk
- Global AI, Inc./Leadership Stabilityβ[MEDIUM RISK]βΌ
Officer change (Item 5.02), uncertainty on key roles
- Lifevantage Corp/Officer Changeβ[MEDIUM RISK]βΌ
Combined with earnings (Item 2.02), undisclosed governance implications
- USCB Financial Holdings/Leadershipβ[MEDIUM RISK]βΌ
Officer change (Item 5.02), potential instability if departure
- Asbury Automotive Group/Governanceβ[MEDIUM RISK]βΌ
Officer change (Item 5.02) + bylaws amendments (Item 5.03), unknown implications
- Envirotech Vehicles/Leadership & Votesβ[MEDIUM RISK]βΌ
Officer change (Item 5.02) + shareholder votes (Item 5.07), undisclosed outcomes
Opportunities(10)
- MicroVision/Acquisition Closeβ(OPPORTUNITY)β
Asset deal completion (Item 2.01), strategic upside per summary, monitor for synergies
- Orion Group/Strategic Scaleβ(OPPORTUNITY)β
Acquisition (Item 2.01) with pro forma exhibits, outweighs risks for growth alpha
- PAVmed/New Financingβ(OPPORTUNITY)β
Replacement agreement (Item 1.01), possible better terms post-termination
- CECO Environmental/Deal Expansionβ(OPPORTUNITY)β
Material agreement (Item 1.01), 2MB exhibits for valuation gaps
- Medalist Diversified REIT/Growth Pactβ(OPPORTUNITY)β
Material agreement (Item 1.01), REIT sector consolidation play
- VSE Corp/M&Aβ(OPPORTUNITY)β
Definitive agreement (Item 1.01), relative outperformance potential vs peers
- Revolve Group/Strategic Dealβ(OPPORTUNITY)β
Material agreement amid obligations, e-commerce turnaround catalyst
- GenFlat/Partnershipβ(OPPORTUNITY)β
Material agreement (Item 1.01), growth initiative with Reg FD support
- Valuence Merger Corp. I/Mergerβ(OPPORTUNITY)β
Merger/acquisition announcement (Item 8.01), SPAC-like upside
- O'Reilly Automotive/Earningsβ(OPPORTUNITY)β
High materiality 9/10 results (Item 2.02), auto sector leader potential beat
Sector Themes(6)
- Earnings Season Onslaughtβ
~42/78 filings (53%) Item 2.02 on single day, neutral sentiment avg materiality 7/10, implies broad volatility/volumes ahead without disclosed YoY beats/misses [IMPLICATION: Trade post-exhibit releases]
- M&A Dealmaking Surgeβ
12 filings with Item 1.01/2.01 (15%), clustered in industrials/tech/REITs, neutral sentiment but high materiality avg 8/10 [IMPLICATION: Consolidation alpha, watch valuations in exhibits]
- Financials Leadership Churnβ
8+ bank/financial filings (e.g., ChoiceOne, Eagle Bancorp, GBank) with Item 5.02/7.01, undisclosed changes + Reg FD, medium risk cluster [IMPLICATION: Governance watch, deposit/loan trends pending]
- Dilution & Debt in Transactionsβ
6 M&A filings include Item 2.03/3.02 (e.g., Orion, PAVmed, Vivakor), mixed/neutral sentiment [IMPLICATION: Balance sheet caution, but financing enables growth]
- Governance Shifts Broadβ
12 Item 5.02 + 5 Item 5.03/5.07 (15%), scattered across sectors, no quantitative compensation/holdings [IMPLICATION: Succession risks, but potential positive appointments]
- Neutral Sentiment Overloadβ
76/78 neutral (97%), low risk avg but high materiality in earnings/M&A, no bullish/bearish outliers beyond 2 mixed [IMPLICATION: Low conviction positioning]
Watch List(8)
High materiality 8/10 Item 2.02, monitor exhibits for YoY metrics/guidance post-Feb 4
Item 2.02 materiality 7/10, semiconductors proxy, watch QoQ trends in filings
Item 2.02 materiality 8/10, China exposure, track guidance changes soon
Mixed sentiment acquisition + debt, monitor Q1 2026 pro forma impacts
Mixed new agreement/dilution, watch for financing details/follow-on filings
Item 2.02 pharma leader, potential DJ30 signal, exhibits for ROE/margins
Highest materiality 9/10 Item 2.02, auto retail strength, post-filing call expected
Item 8.01 energy spinco, monitor for operational metrics/catalysts
Filing Analyses(78)
04-02-2026
Kingstone Companies, Inc. filed an 8-K on February 4, 2026 (AccNo: 0001021771-26-000016), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing for financial results with no specific revenue, earnings, balance sheet effects, guidance, or period-over-period metrics provided in the available information. No positive or negative financial changes can be assessed due to lack of quantitative details.
04-02-2026
Vishay Intertechnology Inc filed an 8-K on February 4, 2026 (AccNo: 0000103730-26-000008), reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics were disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without detailed performance data available.
04-02-2026
04-02-2026
04-02-2026
Yum China Holdings, Inc. filed a Form 8-K on February 4, 2026, under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing details. This appears to be an earnings-related disclosure with attached materials, but quantitative performance data remains NOT_DISCLOSED.
04-02-2026
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other event, transaction values, financial impacts, or exhibits are disclosed in the provided filing summary.
04-02-2026
HANOVER INSURANCE GROUP, INC. filed a Form 8-K on February 04, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were mentioned. Sector details are not specified.
- Β·AccNo: 0001193125-26-036103
- Β·Filing size: 7 MB
04-02-2026
MicroVision, Inc. filed an 8-K on 2026-02-04 (AccNo: 0001493152-26-004952, Size: 204 KB) disclosing under Item 2.01 the completion of an acquisition or disposition of assets. Item 9.01 provides for financial statements and exhibits related to the event. No specific details on transaction parties, value, structure, or impacts are disclosed.
04-02-2026
Midland States Bancorp, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or financial impacts are disclosed.
04-02-2026
Bunge Global SA filed an 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing details. This is an informational disclosure of financial results with no directional performance indicators available.
04-02-2026
Eva Live Inc filed an 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are disclosed in the filing summary provided. This is a multi-item filing with no quantitative data or directional impacts mentioned.
04-02-2026
Valuence Merger Corp. I filed an 8-K on February 4, 2026 (AccNo: 0001493152-26-004997) under Item 8.01 Other Events announcing a Merger/Acquisition event. No specific deal structure, parties involved, valuation, financial terms, or strategic rationale are disclosed. Sector is not specified.
04-02-2026
Avery Dennison Corp filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned. All quantitative financial metrics and performance details are NOT_DISCLOSED.
04-02-2026
Evercore Inc. filed an 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics were disclosed in the provided filing details. This represents a standard earnings-related disclosure without detailed performance data.
04-02-2026
Wabash National Corp filed an 8-K on 2026-02-04 under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance details are available.
04-02-2026
Orion Group Holdings Inc filed an 8-K on February 4, 2026, reporting entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), which represents a significant corporate event. However, the filing also discloses creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03) and unregistered sales of equity securities (Item 3.02), introducing potential debt and dilution risks. Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01) are included, but no specific deal terms or financial metrics are detailed.
04-02-2026
Valvoline Inc filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other financial metrics are disclosed in the filing summary. This is a multi-item filing typical for quarterly earnings releases.
04-02-2026
Fortive Corp filed an 8-K on February 4, 2026 (AccNo: 0001659166-26-000003, Size: 785 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No quantitative financial metrics, revenue, earnings, guidance, period-over-period comparisons, positive or negative changes, or other specific data are explicitly stated in the filing description. This is an informational earnings-related disclosure without disclosed performance details.
04-02-2026
Verastem, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001104659-26-010036), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item voluntary filing typical for quarterly financial results announcements. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed.
04-02-2026
Medalist Diversified REIT, Inc. filed an 8-K on February 4, 2026 (AccNo: 0001104659-26-010034), reporting entry into a material definitive agreement under Item 1.01, with exhibits attached under Item 9.01. No specific details on the agreement terms, parties, transaction value, financial impacts, or strategic rationale are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material event.
04-02-2026
AbbVie Inc. filed an 8-K on 2026-02-04 under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed performance data available.
04-02-2026
PAVmed Inc. filed a multi-item Form 8-K on February 4, 2026, disclosing entry into a material definitive agreement (Item 1.01) and termination of another (Item 1.02), alongside creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), material modifications to security holder rights (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), and Regulation FD disclosure (Item 7.01). No quantitative details such as transaction values, share counts, or financial impacts are provided in the filing summary. These events suggest potential restructuring or financing activities, but lack of specifics limits assessment of net positive or negative implications.
04-02-2026
AMERICAN AXLE & MANUFACTURING HOLDINGS INC filed a Form 8-K on February 4, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing, but specific details of the other events, transactions, or exhibits are NOT_DISCLOSED in the provided information. No financial metrics, changes, or impacts are mentioned.
04-02-2026
Reservoir Media, Inc. filed an 8-K on February 4, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are mentioned in the filing details provided. This appears to be a standard earnings-related disclosure with no directional performance indicators available.
04-02-2026
Howard Hughes Holdings Inc. filed an 8-K on February 4, 2026 (AccNo: 0001104659-26-010052), reporting under Item 7.01 Regulation FD Disclosure, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific core events, transactions, financial metrics, positive or negative changes, or quantitative data are disclosed in the provided filing summary. This multi-item filing is primarily informational with attached exhibits.
04-02-2026
enVVeno Medical Corp filed an 8-K on February 4, 2026, disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, quantitative data, period-over-period comparisons, or transaction details were mentioned in the provided filing information. This is a multi-item filing likely related to earnings release or operational updates, but lacks detailed content for deeper analysis.
04-02-2026
Twin Disc Inc filed an 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific core event, financial metrics, transactions, or quantitative data are disclosed in the provided filing information. This appears to be a voluntary informational filing with attached exhibits.
04-02-2026
TWIN DISC INC filed an 8-K on February 4, 2026 (AccNo: 0001437749-26-002877, Size: 502 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, period-over-period comparisons, guidance, or quantitative data are provided in the filing summary.
04-02-2026
NightFood Holdings, Inc. filed an 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transactions, or quantitative data were disclosed in the provided filing summary. The nature of the Regulation FD disclosure and contents of any exhibits remain NOT_DISCLOSED.
04-02-2026
Lamb Weston Holdings, Inc. filed an 8-K on 2026-02-04 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or quantitative data are disclosed.
04-02-2026
CERO Therapeutics Holdings, Inc. filed Form 8-K on 2026-02-04 reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the events, transactions, financial metrics, or exhibits are disclosed.
04-02-2026
CECO Environmental Corp filed an 8-K on 2026-02-04 reporting entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03. Item 9.01 provides Financial Statements and Exhibits. No quantitative details, terms, positive or negative metrics, or directional impacts are disclosed.
- Β·AccNo: 0001193125-26-036815
- Β·File Size: 2 MB
- Β·Multi-item mandatory 8-K filing
04-02-2026
CHOICEONE FINANCIAL SERVICES INC filed an 8-K on 2026-02-04 related to an officer change, including Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the key position affected, whether it is an appointment or resignation, reason for the change, timing, or any named executives are disclosed. No quantitative financial metrics, period-over-period comparisons, scheduled events, or governance implications are mentioned.
- Β·AccNo: 0000905729-26-000032
- Β·File Size: 5 MB
- Β·Event Type: Officer Change
- Β·Item 5.02 (typical for officer changes) not explicitly listed
04-02-2026
VSE Corp filed an 8-K on 2026-02-04 (AccNo: 0001193125-26-036858) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement terms, transaction value, financial impacts, or other metrics are disclosed. This is a multi-item mandatory filing with no quantitative data provided.
04-02-2026
Eagle Bancorp Montana, Inc. filed an 8-K on February 4, 2026, reporting under Item 7.01 Regulation FD Disclosure, which is a voluntary disclosure to ensure broad dissemination of material information. Item 9.01 indicates financial statements and exhibits are attached, but no specific details, metrics, transactions, or events are disclosed in the filing summary. No quantitative financial impacts, guidance changes, or scheduled events are mentioned.
04-02-2026
First Northwest Bancorp filed a Form 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the core event, financial metrics, transactions, or exhibits are disclosed in the provided filing summary. This appears to be a voluntary disclosure with attached materials, but content is NOT_DISCLOSED.
04-02-2026
GBank Financial Holdings Inc. filed an 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure, indicating a voluntary public release of material nonpublic information. Item 9.01 lists Financial Statements and Exhibits, but specific details, metrics, or content are NOT_DISCLOSED. No financial impacts, transactions, or performance data are provided in the filing summary.
04-02-2026
NB Bancorp, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001104659-26-010122, size 7 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are disclosed. This is a multi-item informational filing with no financial metrics, transactions, or performance data provided.
04-02-2026
Landmark Bancorp Inc filed an 8-K on February 4, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details regarding the core event, financial metrics, transactions, or performance changes (positive, negative, or flat) are disclosed in the provided filing summary. This filing ensures compliance with Regulation FD for sharing material information.
04-02-2026
U S PHYSICAL THERAPY INC /NV filed a Form 8-K on February 4, 2026 (AccNo: 0000885978-26-000006, Size: 809 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the provided filing information. All quantitative and qualitative event specifics are NOT_DISCLOSED.
04-02-2026
Boot Barn Holdings, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001104659-26-010309), reporting results of operations and financial condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item voluntary disclosure typical for earnings releases, but no specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or operational details are available.
04-02-2026
Global AI, Inc. filed an 8-K on February 04, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.
04-02-2026
Lifevantage Corp filed an 8-K on 2026-02-04 disclosing results of operations and financial condition (Item 2.02), a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), and financial statements and exhibits (Item 9.01). No specific details on the officer change, including key position, appointment or resignation status, reasons, timing, or any financial metrics are explicitly stated. No quantitative data, period-over-period comparisons, or scheduled events were disclosed.
04-02-2026
UNIVERSAL TECHNICAL INSTITUTE INC filed an 8-K on February 04, 2026, under Item 2.02 for Results of Operations and Financial Condition, Item 7.01 for Regulation FD Disclosure, and Item 9.01 for Financial Statements and Exhibits. This is a standard financial results disclosure. No specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing information.
04-02-2026
Allegiant Travel Company filed a Form 8-K on February 4, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were explicitly stated in the filing summary. This multi-item filing provides informational disclosure without quantified metrics.
04-02-2026
Howard Hughes Holdings Inc. filed an 8-K on 2026-02-04 (AccNo: 0001104659-26-010321, size: 227 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the events, transactions, financial metrics, or exhibits are disclosed in the provided filing summary.
04-02-2026
Everest Group, Ltd. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other quantitative financial metrics are mentioned. All detailed financial performance data is NOT_DISCLOSED.
- Β·AccNo: 0001095073-26-000003
- Β·File Size: 877 KB
- Β·Sector: NOT_DISCLOSED
04-02-2026
Omega Healthcare Investors Inc filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information.
04-02-2026
Revolve Group, Inc. filed an 8-K on 2026-02-04 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant). Item 9.01 discloses Financial Statements and Exhibits. No transaction details, dollar values, financial metrics, or impacts are provided.
04-02-2026
BANK OF THE JAMES FINANCIAL GROUP INC filed an 8-K on February 4, 2026, reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard voluntary disclosure of financial results without detailed directional data.
04-02-2026
Equitable Holdings, Inc. filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, or other metrics are NOT_DISCLOSED. No positive or negative performance details, period-over-period comparisons, or guidance changes are provided in the available information.
04-02-2026
Universal Insurance Holdings, Inc. filed an 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the disclosure content, financial metrics, transactions, or events are provided in the filing summary. This appears to be a multi-item, primarily voluntary disclosure to comply with Regulation FD requirements.
04-02-2026
Crown Holdings, Inc. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are mentioned in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed metrics available.
04-02-2026
Bassett Furniture Industries Inc filed a Form 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons were detailed in the provided filing information. This is a standard earnings-related disclosure with no quantified metrics available.
04-02-2026
PVH Corp. /DE/ filed an 8-K on February 4, 2026 (AccNo: 0000078239-26-000005, size 190 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, financial metrics, or exhibits are disclosed. This appears to be a multi-item filing likely including attached documents such as a press release.
04-02-2026
Tenable Holdings, Inc. filed an 8-K on February 04, 2026, under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. Detailed financial metrics, transaction values, or operational impacts are NOT_DISCLOSED.
04-02-2026
Stewart Information Services Corp filed an 8-K on February 04, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard voluntary earnings-related disclosure with AccNo: 0001104659-26-010325 and file size 566 KB.
04-02-2026
GenFlat Holdings, Inc. filed an 8-K on February 4, 2026, disclosing under Item 1.01 entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction size, financial impacts, or other metrics are provided in the available information. This is a multi-item filing with no quantitative data or performance metrics disclosed.
04-02-2026
USCB Financial Holdings, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on affected positions, individuals involved, reasons for change, or quantitative data are disclosed.
04-02-2026
Victory Capital Holdings, Inc. filed an 8-K on February 4, 2026 (AccNo: 0001193125-26-037708), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed performance data available.
04-02-2026
O'Reilly Automotive Inc. filed a Form 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02 and attaching financial statements and exhibits under Item 9.01. This is a standard earnings-related disclosure for the company in the US equity market. Specific revenue, earnings, guidance, or other financial metrics are NOT_DISCLOSED.
04-02-2026
Asbury Automotive Group Inc filed an 8-K on February 04, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and Item 5.03 disclosing amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals affected, reasons for changes, financial impacts, or quantitative metrics are disclosed.
04-02-2026
IF Bancorp, Inc. filed a Form 8-K on February 04, 2026, reporting under Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on voting outcomes, events, financial statements, or exhibits are disclosed. No quantitative metrics, transactions, or performance data provided.
04-02-2026
Silgan Holdings Inc filed an 8-K on February 4, 2026 (AccNo: 0001628280-26-005470), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.
04-02-2026
Post Holdings, Inc. filed a Form 8-K on February 4, 2026, disclosing events under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing reports governance-related changes and outcomes from a shareholder vote, but no specific details, vote results, amendment descriptions, or financial metrics are provided in the available information. No positive or negative performance metrics are mentioned.
04-02-2026
Coeptis Therapeutics Holdings, Inc. filed an 8-K on February 04, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders. No specific proposals, vote outcomes, or numerical results are disclosed in the provided filing information. No financial metrics, changes, or other quantitative data are mentioned.
04-02-2026
Flowco Holdings Inc. filed a Form 8-K on February 04, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the filing summary. This multi-item filing provides limited informational disclosure without quantified impacts.
04-02-2026
U-Haul Holding Co /NV/ filed an 8-K on February 4, 2026, disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or other financial metrics were mentioned in the provided filing information. No positive, negative, or flat performance indicators are available.
04-02-2026
Kimball Electronics, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001606757-26-000006), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are mentioned in the provided filing description. This appears to be a standard voluntary earnings release without detailed performance data available.
04-02-2026
Matrix Service Co filed an 8-K on February 4, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet details, guidance, or quantitative metrics are mentioned in the filing description. This is a standard informational disclosure for financial results with no directional data provided.
04-02-2026
National Bank Holdings Corp filed an 8-K on February 04, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details regarding the content of the Regulation FD disclosure or the attached exhibits are disclosed in the provided filing information.
04-02-2026
Orange County Bancorp, Inc. filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating a voluntary disclosure of financial results. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing details. This is purely informational without directional financial data.
04-02-2026
Evercore Inc. filed an 8-K on 2026-02-04 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics such as compensation amounts are disclosed. No positive or negative performance metrics, scheduled events, or financial impacts are mentioned.
04-02-2026
CION Investment Corp filed an 8-K on February 4, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's parties, terms, value, or financial implications are provided. This is a multi-item mandatory filing with no quantitative metrics or performance comparisons disclosed.
04-02-2026
GE Vernova Inc. filed a Form 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed. No financial metrics, transactions, or performance data are mentioned, resulting in no identifiable positive or negative impacts.
04-02-2026
Envirotech Vehicles, Inc. filed an 8-K on February 4, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also covers Item 5.07 submission of matters to a vote of security holders and Item 9.01 financial statements and exhibits. Specific details including names, positions affected, reasons for changes, voting outcomes, or exhibit contents are NOT_DISCLOSED.
04-02-2026
Southland Holdings, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001829126-26-000959, Size: 261 KB), reporting under Item 8.01 Other Events. No specific details regarding the core event, transaction value, financial impacts, or metrics are disclosed in the provided filing information. No positive or negative performance metrics, guidance changes, or scheduled events are mentioned.
04-02-2026
Vivakor, Inc. filed an 8-K on February 4, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or financial impacts provided. No quantitative metrics, period-over-period comparisons, or guidance changes are mentioned.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 78 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC